DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
| Montrouge, France, February 4, 2019 |
DBV Technologies to Present Data on Epicutaneous Immunotherapy at AAAAI 2019
Novel immunotherapy based on Viaskin technology highlighted as a potential treatment for food-allergic patients
DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical and pre-clinical data from its Viaskin technology platform were accepted for poster presentation at the 2019 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting; Food Allergy: Advances in Prevention and Treatment in San Francisco, CA, February 22 -25, 2019. The abstracts became available on the AAAAI meeting website on February 4th.
"It is exciting to see the AAAAI highlight food allergies as a serious unmet medical need, and we look forward to underscoring epicutaneous immunotherapy as a potentially important clinical advancement in treating these diseases," said Dr. Hugh Sampson, Chief Scientific Officer and Interim Chief Medical Officer of DBV Technologies and Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai. "Epicutaneous immunotherapy, by using the skin to activate the immune system, offers a novel way to potentially transform how we treat our food-allergic patients in a non-invasive manner."
Selected Abstracts of Interest:
Peanut Allergy Data
"Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis" will be presented by Dr. Carla M. Davis, Texas Children's Hospital and Baylor College of Medicine, Houston, TX.
- Poster Number: 735
- Session Number: 4208
- Session Title: Food Immunotherapy
- Poster Hall Location: Moscone Center South, Exhibition Level, Hall B
- Presentation Date: Monday, February 25, 2019
- Presentation Time: 9:45am-10:45am
"Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children" will be presented by Dr. David Fleischer, Director, Allergy and Immunology Center and Associate Section Head, Children's Hospital Colorado
- Poster Number: 749
- Session Number: 4208
- Session Title: Food Immunotherapy
- Poster Hall Location: Moscone Center South, Exhibition Level, Hall B
- Presentation Date: Monday, February 25, 2019
- Presentation Time: 9:45am-10:45am
EPIT Mechanism of Action Research
0 Kommentare
| 
